Patents by Inventor Esther Rabizadeh

Esther Rabizadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DIAGNOSING MALIGNANT DISEASES
    Publication number: 20230109120
    Abstract: A method for diagnosing a malignant proliferative disease or disorder in a subject, and/or for following up, monitoring or prognosticating the therapy of a malignant proliferative disease or disorder in a subject is disclosed. The method is based on measurement of platelet-mediated fibrinogen-like protein 2 (FGL2) activity in a sample essentially comprising platelets obtained from the subject. In accordance with the disclosed method, platelet-mediated FGL2 activity level higher than control is indicative of the presence of a malignant proliferative disease or disorder in a subject.
    Type: Application
    Filed: December 4, 2022
    Publication date: April 6, 2023
    Applicant: ST INNOVATIVE DIAGNOSTICS LTD
    Inventor: ESTHER RABIZADEH
  • Methods of diagnosing malignant diseases
    Patent number: 11519914
    Abstract: A method for diagnosing a malignant proliferative disease or disorder in a subject, and/or for following up, monitoring or prognosticating the therapy of a malignant proliferative disease or disorder in a subject is disclosed. The method is based on measurement of platelet-mediated fibrinogen-like protein 2 (FGL2) activity in a sample essentially comprising platelets obtained from the subject. In accordance with the disclosed method, platelet-mediated FGL2 activity level higher than control is indicative of the presence of a malignant proliferative disease or disorder in a subject.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: December 6, 2022
    Assignee: ST INNOVATIVE DIAGNOSTICS LTD
    Inventor: Esther Rabizadeh
  • METHODS OF DIAGNOSING MALIGNANT DISEASES
    Publication number: 20190383815
    Abstract: A method for diagnosing a malignant proliferative disease or disorder in a subject, and/or for following up, monitoring or prognosticating the therapy of a malignant proliferative disease or disorder in a subject is disclosed. The method is based on measurement of platelet-mediated fibrinogen-like protein 2 (FGL2) activity in a sample essentially comprising platelets obtained from the subject. In accordance with the disclosed method, platelet-mediated FGL2 activity level higher than control is indicative of the presence of a malignant proliferative disease or disorder in a subject.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 19, 2019
    Inventors: Esther RABIZADEH, Izchak CHERNY, Aida INBAL
  • FGL-2 prothrombinase as a diagnostic tool for malignancy
    Patent number: 9023609
    Abstract: The present invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: May 5, 2015
    Assignees: Mor Research Applications Ltd., Ramot at Tel-Aviv University Ltd.
    Inventors: Aida Inbal, Esther Rabizadeh
  • FGL-2 PROTHROMBINASE AS A DIAGNOSTIC TOOL FOR MALIGNANCY
    Publication number: 20130115645
    Abstract: The present: invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy.
    Type: Application
    Filed: July 11, 2011
    Publication date: May 9, 2013
    Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD., MOR RESEARCH APPLICATIONS LTD.
    Inventors: Aida Inbal, Esther Rabizadeh